GAMMA Investing
BCYC icon

GAMMA Investing’s Bicycle Therapeutics BCYC Stock Holding History

GAMMA Investing’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.8K Sell
7,561
-143
-2% -$578 ﹤0.01% 2740
2026
Q2 		$32.7K Buy
7,704
+6,447
+513% +$29.6K ﹤0.01% 2563
2026
Q1 		$5.83K Sell
1,257
-129
-9% -$737 ﹤0.01% 3308
2025
Q4 		$9.81K Sell
1,386
-730
-34% -$5.38K ﹤0.01% 2987
2025
Q3 		$16.4K Buy
2,116
+628
+42% +$4.74K ﹤0.01% 2623
2025
Q2 		$10.3K Buy
1,488
+430
+41% +$3.42K ﹤0.01% 2783
2025
Q1 		$8.98K Buy
1,058
+141
+15% +$1.66K ﹤0.01% 2802
2024
Q4 		$12.8K Sell
917
-1,109
-55% -$23.8K ﹤0.01% 2480
2024
Q3 		$45.8K Buy
2,026
+1,038
+105% +$23.9K ﹤0.01% 1549
2024
Q2 		$20K Buy
988
+117
+13% +$2.64K ﹤0.01% 1854
2024
Q1 		$21.7K Buy
871
+349
+67% +$7.41K ﹤0.01% 1599
2023
Q4 		$9.11K Buy
+522
New +$8.64K ﹤0.01% 1959

Other funds holding BCYC

WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

GAMMA Investing's BCYC Position: Q3 2026 in Review

GAMMA Investing reduced its Bicycle Therapeutics (BCYC) stake by 1.9% in Q3 2026, selling an estimated $578 and leaving 7,561 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

GAMMA Investing first reported a position in BCYC in Q4 2023 and has held it in 12 quarters since. The position peaked at $45.8K in Q3 2024. 2 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • GAMMA Investing held 7,561 shares of Bicycle Therapeutics worth $27.8K as of Q3 2026.
  • GAMMA Investing sold 143 Bicycle Therapeutics shares in Q3 2026, an estimated $578.
  • Bicycle Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2740 holding.
  • GAMMA Investing first reported a position in Bicycle Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Bicycle Therapeutics position peaked at $45.8K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.